ClinicalTrials.govpublic full text
A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease
neoplasm, antifolate, inhibitor, pharmacokinetics, thymidylate synthetase, toxicity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803420
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.